The Wall Street Journal dropped a lengthy hit piece insinuating that billionaire entrepreneur Elon Musk has a drug problem. Quoting anonymous sources, the article alleges that Musk frequently uses marijuana, cocaine, LSD, and psilocybin, and has a prescription for ketamine. It then challenges typical defenses of Musk’s “provocative” behavior, such as that he is stressed, sleep deprived, or simply too creative for most, and suggests instead that he is a substance abuser.
The propagation of this theory could cause investors to second-guess their trust in Musk, who runs at least six major companies and oversees billions upon billions of dollars.
Learn the benefits of becoming a Valuetainment Member and subscribe today!
Musk, 52, allegedly attends exclusive parties across the globe where guests are required to sign non-disclosure agreements (NDAs) and give up electronic devices so that drugs can be consumed freely. According to the sources, Musk hosted a party in Los Angeles in 2018 during which he ingested multiple tabs of LSD. In 2019, he took mushrooms at a party in Mexico. In 2021, he attended a house party during Art Basel in Miami and took ketamine with his brother Kimball. He has also reportedly taken drugs with SpaceX board member (and former board member of Tesla) Steve Jurvetson.
Elon Musk’s use of drugs—including LSD, cocaine, ecstasy, mushrooms and ketamine—has made some Tesla and SpaceX leaders worry about potential risk to his companies. https://t.co/ZHQip3uPAT https://t.co/ZHQip3uPAT
— The Wall Street Journal (@WSJ) January 7, 2024
The sources claim that Musk’s drug use is not a thing of the past but an ongoing habit, and they expressed concerns to the Journal that it could affect both his health and his businesses. Additionally, Musk is tied up with multiple government contracts worth billions of dollars, and the Journal suggests that federal policies would force those contracts to be terminated if his drug habit became known.
Linda Johnson Rice, a former director of Tesla, chose not to stand for re-election in 2019 due to her exasperation with his behavior and his drug use, according to sources who spoke with the Journal.
Musk’s attorney Alex Spiro rejected the allegations, saying that his client is “regularly and randomly drug tested at SpaceX and has never failed a test.” Spiro told the WSJ reporter that their article had many mistakes, but did not offer specifics. Musk also declined to offer comment.
My mother just told me Italian news stations are repeating non-stop that @elonmusk is doing mushrooms, cocaine and all sorts of other drugs. Time to sue their asses. pic.twitter.com/fNflgK1Spi
— whatsupfranks (@WhatsupFranks) January 8, 2024
SpaceX rocket launches are purchased by the Pentagon, and SpaceX has clearance to transport NASA personnel to the International Space Station (ISS). SpaceX also has contracts with the European Union (EU) and is aiming to develop satellite services curated for America’s national security agencies. Musk plays a central role in all of these efforts, representing possibly $1 trillion in investor assets and many thousands of jobs. Scrutiny over his ability to lead could lead to massive disruptions for the United States’ space program among dozens of other ventures.
As Mollie Hemingway of The Federalist writes, the report comes off as an antagonistic attempt to reduce Musk’s so-called “erratic” Twitter/X usage—which boils down to power moves of defiance in the face of censorship—to a meaningless side-effect of irresponsibility.
Front page of WSJ today is a story asserting Elon Musk's words and actions in defense of free speech and western civilization and against the more radical ideologies of the left are best explained not by independent thought or creativity but by … drug use.
— Mollie (@MZHemingway) January 8, 2024
Shane Devine is a writer covering politics, economics, and culture for Valuetainment. Follow Shane on X (Twitter).
Add comment